Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesRensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
EurekAlert, 09/18/09
In early 2008, there was a frightening failure in drug safety processes. In just a few weeks, more than 100 Americans had died after being administered contaminated doses of the common blood thinner heparin. The contaminant, present in heparin manufactured in China and discovered with the help of scientists from Rensselaer Polytechnic Institute, was so structurally similar to pure heparin that is was undetectable to all but the most sophisticated detection techniques. As a result, many people became seriously ill or died around the world and the several hundred thousand patients that receive the drug every day in the U.S. were put at risk.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Polymer therapeutic protects gut from radiation damage, infection after cancer treatment
EurekAlert, 12/04/09
Cigarette smoking increases colorectal cancer risk
ScienceDaily, 12/04/09
Hepatitis C drug fights virus in new way
Reuters, 12/04/09
Sponsor
Article Search
Sponsor